MARKET

PLX

PLX

Protalix Biother
AMEX
2.670
+0.020
+0.75%
After Hours: 2.640 -0.03 -1.12% 17:31 09/09 EDT
OPEN
2.680
PREV CLOSE
2.650
HIGH
2.680
LOW
2.595
VOLUME
580.00K
TURNOVER
--
52 WEEK HIGH
3.190
52 WEEK LOW
1.530
MARKET CAP
215.13M
P/E (TTM)
11.80
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLX last week (0831-0904)?
Weekly Report · 2d ago
Weekly Report: what happened at PLX last week (0824-0828)?
Weekly Report · 08/31 09:35
Weekly Report: what happened at PLX last week (0817-0821)?
Weekly Report · 08/24 09:36
Protalix Biotherapeutics Earnings Call Signals Strong Momentum
TipRanks · 08/24 00:16
Weekly Report: what happened at PLX last week (0810-0814)?
Weekly Report · 08/17 09:36
Protalix BioTherapeutics GAAP EPS of $0.05 beats by $0.06, revenue of $19.8M beats by $6.87M
Seeking Alpha · 08/12 10:57
Protalix BioTherapeutics Q2 EPS $0.05 Misses $0.12 Estimate, Sales $19.896M Beat $12.931M Estimate
Benzinga · 08/12 10:51
Here are the major earnings before the open Wednesday
Seeking Alpha · 08/11 22:00
More
About PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.